BSE Live
Oct 03, 16:01Prev. Close
43.54
Open Price
45.01
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Key Financial Ratios of Bacil Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 0.64 | -0.10 | -0.17 | -6.55 | -0.41 | |
Diluted EPS (Rs.) | 0.64 | -0.10 | -0.17 | -6.55 | -0.41 | |
Cash EPS (Rs.) | 0.29 | -0.09 | -0.15 | -5.91 | -0.36 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 18.20 | 1.86 | 1.68 | 1.88 | 2.13 | |
Book Value [InclRevalReserve]/Share (Rs.) | 18.20 | 1.86 | 1.68 | 1.88 | 2.13 | |
Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PBDIT/Share (Rs.) | 0.29 | -0.09 | -0.15 | -5.91 | -0.36 | |
PBIT/Share (Rs.) | 0.29 | -0.09 | -0.16 | -5.91 | -0.37 | |
PBT/Share (Rs.) | 0.29 | -0.09 | -0.16 | -5.91 | -0.37 | |
Net Profit/Share (Rs.) | 0.29 | -0.09 | -0.16 | -5.91 | -0.37 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Return on Networth / Equity (%) | 1.58 | -4.85 | -9.26 | -315.24 | -17.19 | |
Return on Capital Employed (%) | 1.60 | -4.86 | -9.26 | -315.26 | -17.22 | |
Return on Assets (%) | 1.57 | -4.44 | -9.03 | -303.54 | -5.85 | |
Total Debt/Equity (X) | 0.01 | 0.08 | 0.02 | 0.03 | 0.13 | |
Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 17.64 | 0.46 | 8.19 | 10.63 | 1.04 | |
Quick Ratio (X) | 17.64 | 0.46 | 8.19 | 10.63 | 1.04 | |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 22.33 | 9.61 | 3.57 | 3.54 | 2.11 | |
EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EV/EBITDA (X) | 138.79 | -168.53 | -35.97 | -0.92 | -9.00 | |
MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 2.33 | 7.87 | 3.25 | 3.06 | 1.46 | |
Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield | 0.01 | -0.01 | -0.03 | -1.03 | -0.12 |